A French producer of therapeutic vaccines for cancer has raised €13.1 million from private and public sources in order to bring its lead product, a therapeutic human papillomavirus vaccine, into the clinic. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
